Novo Nordisk veteran takes up CMO position at Danish-Swedish biotech company
![Synact Pharma CEO Jeppe Øvlesen | Photo: Synact Pharma / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13115468.ece/ALTERNATES/schema-16_9/doc7gjtgn6dsed9zrgwcmd.jpg)
On Wednesday, SynAct Pharma appointed Anders Dyhr Toft as its Chief Medical Officer (CMO). This will come into effect on Aug. 1, according to a company press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk launches smart insulin pen in Denmark
For subscribers